Developmental pattern of fetal growth hormone, insulin-like growth factor I, growth hormone binding protein and insulin-like growth factor binding protein-3

被引:16
|
作者
Pirazzoli, P
Cacciari, E
DeIasio, R
Pittalis, MC
Dallacasa, P
Zucchini, S
Gualandi, S
Salardi, S
David, C
Boschi, S
机构
[1] UNIV BOLOGNA, ST ORSOLA HOSP, CENT LAB, DEPT PAEDIAT, I-40126 BOLOGNA, ITALY
[2] UNIV BOLOGNA, INST OBSTET & GYNAECOL, PRENATAL PATHOPHYSIOL UNIT, I-40126 BOLOGNA, ITALY
[3] UNIV BOLOGNA, CLIN PHARMACOL UNIT, I-40126 BOLOGNA, ITALY
来源
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION | 1997年 / 77卷 / 02期
关键词
insulin-like growth factor I; IGF-binding protein; growth hormone-binding protein; somatotropin; INTRAUTERINE GROWTH; HUMAN FETUS; HUMAN-PREGNANCY; FACTOR (IGF)-I; FACTORS IGFS; GH RECEPTOR; SERUM; DEFICIENCY; TERM; RETARDATION;
D O I
10.1136/fn.77.2.F100
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Aims-To evaluate the developmental pattern of fetal growth hormone (GH), insulin-like growth factor I (IGF-I), GH binding protein (GHBP) and IGF binding protein-3 (IGF-3); to determine the implications for fetal growth. Methods-Serum GH, IGF-I, GHBP and IGFBP-3 were measured in 53 fetuses, 41 aged 20-26 weeks (group A) and 12 aged 31-38 weeks (group B). Fetal blood samples were obtained by direct puncture of the umbilical vein in utero. Fetal blood samples were taken to rule out beta thalassaemia, chromosome alterations, mother to fetus transmissible infections, and for maternal rhesus factor. GHBP was determined by gel filtration chromatography of serum incubated overnight with I-125-GH. GH, IGF-I and IGFBP-3 were determined by radioimmunoassay. Results-Fetal serum GH concentrations in group A (median 29 mu g/l, range 11-92) were significantly higher (P<0.01) than those of group B (median 16.7 mu g/l, range 4.5-29). IGF-I in group A (median 20 mu g/l, range 4.1-53.3) was significantly lower (P<0.01) than in group B (median 75.2 mu g/l, range 27.8-122.3). IGFBP-3 concentrations in group A (median 950 mu g/l, range 580-1260) were significantly lower than those of group B (median 1920 mu g/l, range 1070-1770). There was no significant difference between GHBP values in group A (median 8.6%, range 6.6-12.6) and group B (median 8.3%, range 6-14.3). Gestational age correlated positively with IGF-I concentrations (P<0.0001) and IGFBP-3 (P<0.0001) and negatively with GH (P<0.0001). GHBP values did not correlate with gestational age. Multiple regression analysis showed a negative correlation between GH:IGF-I ratio and fetal growth indices. Conclusions The simultaneous evaluation of fetal GH, IGF-I, IGFBP-3 and GHBP suggests that the GH-IGF-I axis might already be functional in utero. The progressive improvement in the efficiency of this axis in the last part of gestation does not seem to be due to an increase in GH receptors.
引用
收藏
页码:F100 / F104
页数:5
相关论文
共 50 条
  • [21] Insulin-like growth factor axis (insulin-like growth factor-I/insulin-like growth factor-binding protein-3) as a prognostic predictor of heart failure: association with adiponectin
    Watanabe, Shin
    Tamura, Toshihiro
    Ono, Koh
    Horiuchi, Hisanori
    Kimura, Takeshi
    Kita, Toru
    Furukawa, Yutaka
    EUROPEAN JOURNAL OF HEART FAILURE, 2010, 12 (11) : 1214 - 1222
  • [22] Effects of alcohol on insulin-like growth factor I and insulin-like growth factor binding protein 3 in postmenopausal women
    Lavigne, JA
    Baer, DJ
    Wimbrow, HH
    Albert, PS
    Brown, ED
    Judd, JT
    Campbell, WS
    Giffen, CA
    Dorgan, JF
    Hartman, TJ
    Barrett, JC
    Hursting, SD
    Taylor, PR
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2005, 81 (02) : 503 - 507
  • [23] Growth hormone-stimulated insulin-like growth factor (IGF) I and IGF-binding protein-3 in liver cirrhosis
    Assy, N
    Hochberg, Z
    Amit, T
    ShenOrr, Z
    Enat, R
    Baruch, Y
    JOURNAL OF HEPATOLOGY, 1997, 27 (05) : 796 - 802
  • [24] Maternal Concentrations of Insulin-like Growth Factor I and Insulin-like Growth Factor Binding Protein 1 During Pregnancy and Birth Weight of Offspring
    Asvold, Bjorn Olav
    Eskild, Anne
    Jenum, Pal A.
    Vatten, Lars J.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2011, 174 (02) : 129 - 135
  • [25] Associations of insulin-like growth factor-I and insulin-like growth factor binding protein-3 with bone quality in the general adult population
    Boeker, J.
    Voelzke, H.
    Nauck, M.
    Hannemann, A.
    Friedrich, N.
    CLINICAL ENDOCRINOLOGY, 2018, 88 (06) : 830 - 837
  • [26] Effect of celiac disease and gluten-free diet on growth hormone-binding protein, insulin-like growth factor-I, and insulin-like growth factor-binding proteins
    Federico, G
    Favilli, T
    Cinquanta, L
    Ughi, C
    Saggese, G
    HORMONE RESEARCH, 1997, 48 (03) : 108 - 114
  • [27] Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 following chemotherapy for advanced breast cancer
    Holdaway, IM
    Mason, BH
    Lethaby, AE
    Singh, V
    Harvey, VJ
    Thompson, PI
    Evans, BD
    ANZ JOURNAL OF SURGERY, 2003, 73 (11) : 905 - 908
  • [28] Serum concentrations of insulin-like growth factor-I, insulin-like growth factor binding protein-3 and cardiovascular risk factors in adolescents
    Kong, Alice P. S.
    Choi, Kai-Chow
    Wong, Gary W. K.
    Ko, Gary T. C.
    Ho, Chung-Shun
    Chan, Michael H. M.
    Ozaki, Risa
    Ma, Ronald C. W.
    Lau, Joseph T. F.
    Chan, Juliana C. N.
    ANNALS OF CLINICAL BIOCHEMISTRY, 2011, 48 : 263 - 269
  • [29] INSULIN-LIKE GROWTH FACTOR-I, GROWTH HORMONE-DEPENDENT INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN AND GROWTH IN CHILDREN WITH CHRONIC-RENAL-FAILURE
    HODSON, EM
    BROWN, AS
    ROY, LP
    ROSENBERG, AR
    PEDIATRIC NEPHROLOGY, 1992, 6 (05) : 433 - 438
  • [30] Insulin-like growth factor I, insulin-like growth factor binding protein 3, and urologic measures of benign prostatic hyperplasia
    Roberts, RO
    Jacobson, DJ
    Girman, CJ
    Rhodes, T
    Klee, GG
    Lieber, MM
    Jacobsen, SJ
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2003, 157 (09) : 784 - 791